PathogenDx
Business Services · Arizona, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1230 E Pennsylvania St Ste 102, Tucson, ...Phone Number
(800) 641-5751Website
www.pathogendx.comRevenue
$16.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About PathogenDx
PathogenDx specializes in advanced pathogen testing technology, offering solutions for the cannabis, life sciences, and food industries. Their proprietary D³ Dynamic Dimensional Detection Array technology enables rapid and accurate detection of multiple pathogens simultaneously, addressing the limitations of traditional testing methods. Founded in 2014, the company provides testing kits, automation, and software to enhance health and safety across various sectors. With a focus on innovation, PathogenDx partners with over 120 laboratories to ensure regulatory compliance and integrity in cannabis testing.Explore more
PathogenDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PathogenDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if PathogenDx had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at PathogenDx
Website visits: Recent activity has been detected on your website
Check out if PathogenDx is spiking on competitors!
PathogenDx, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once PathogenDx has new funding data
Earning: See what the market has to say on PathogenDx recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if PathogenDx has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when PathogenDx launches new products
Recommended Actions
Reach out to Masked Content who joined PathogenDx as Masked Content
Find more new buyers
Compare Similar Companies to PathogenDx
Compare insights from companies similar to PathogenDx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PathogenDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PathogenDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PathogenDx.
PathogenDx financials insights
Gather financial insights about PathogenDx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$675K
2018
Series A
$3.4M
2019
Series B
$7.5M
2020
Debt
$150K
PathogenDx Tech Stack
A closer look at the technologies used by PathogenDx
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Automation, Sales, Safety, Logistics / Supply Chain, Food & Beverage, Field /Outside Sales, Field Marketing, Health & Safety, Manufacturing Operations, Operations
Award
Award, Product Development, Product Management
Award
Award, Research & Development
Funding
Funding
PathogenDx News & Media
Carl Wittwer, MD, PhD, Joins PathogenDx’s Board of Advisors
Carl Wittwer, MD PhD, Professor Emeritus of Pathology at the University of Utah, a Co-Founder of Idaho Technologies/Biofire and previously spent 35+ years as a Medical Director at ARUP Laboratories is joining PathogenDx as Technology & Scientific Board Advisor to help advance its D3 Array technology in terms of Speed, Cost and Performance. [PR.com]PathogenDx Launches Its Rebranded D3 Array™ Combined, Bacterial and Fungal Assays—Delivering Value in Turn-Around Time, Cost and Throughput to Testing Labs
PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of its new rebranded D3 Array™ Combined, Bacterial and Fungal assays to replace Detectx–Combined,Detectx-Bacterial and Detectx-Fungal tests. [PR.com]PathogenDx Launches the Cannabis Industry's First AOAC Certified Rapid Semi-Quantification Test for Total Yeast and Mold with Results in a Single-Shift
Scottsdale, Arizona--(Newsfile Corp. - October 11, 2023) - PathogenDx (PathogenDx or Company), a leader in next-generation microarray technology for better health and safety, announced the launch of its new and improved rapid semi-quantification assay, QuantX Fungal, which has received an AOAC® Performance Tested Methods (PTM) SM Certificate to semi-quantify fungal species in total yeast and mold (TYM) for cannabis flower. Quantx Fungal joins the Company's comprehensive suite of cannabis testingPathogenDx Enables Labs to Meet Cannabis Testing Regulations in Every State With Launch of Rapid Bacterial Semi-Quantification Four-in-One Test
Scottsdale, Arizona--(Newsfile Corp. - August 15, 2023) - PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of QuantX Bacterial, a new rapid bacterial semi-quantification four-in-one assay that enables cannabis testing labs to efficiently meet any state's microbial testing regulations. The QuantX Bacterial assay simplifies a lab's workflow, streamlines compliance reporting and improves labor efficiency while also delivering results..
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PathogenDx
Sign Up For FreeTo access detailed company insights
PathogenDx specializes in advanced pathogen testing technology, offering solutions for the cannabis, life sciences, and food industries. Their proprietary D³ Dynamic Dimensional Detection Array technology enables rapid and accurate detection of multiple pathogens simultaneously, addressing the limitations of traditional testing methods. Founded in... Read More
